• Geraldine A. Hamilton, PhD: President and Chief Scientific Officer, Emulate, Inc.

• Megan Driscoll: Founder and CEO, PharmaLogics Recruiting
• Julia Rashba-Step: Vice President of Research and Development and Alliance Management, Phosphorex
• Pat Andrews: CEO, Boston Biomedical, Inc.

Biographies

 Geraldine A. Hamilton 

Dr. Hamilton works at the intersection of design, biology and engineering. She led development of the human “Organs-on-Chips” technology during her residency within the Wyss Institute for Biologically Inspired Engineering at Harvard University. Organs-on-Chips has been published in leading scientific journals, curated into New York’s Museum of Modern Art (MoMA) and awarded Product Design of the Year 2015 by London’s Design Museum.

Today, Hamilton is the President and Chief Scientific Officer at Emulate, Inc. The company’s new living system emulates human biology and predicts human response with greater precision and detail than today’s cell culture or animal-based testing approaches. Emulate’s system is being used by industry, government and academia to understand how different diseases, medicines, chemicals and foods affect human health.

Hamilton is also leading a bold new precision medicine and personal health initiative with Emulate’s clinical partners – named “Patient-on-a-Chip”. The program is developing unique human-chips personalized with an individual’s own living cells – to help transform the way each of us can understand our own body, and manage our own health.

Hamilton has co-authored over 40 peer-reviewed publications and numerous patents.

Megan Driscoll

Megan Driscoll is the dynamic Founder and CEO of PharmaLogics Recruiting, a global human capital organization established in 2003 with an exclusive focus in placement of life science professionals.  With a staff of over 85 employees and an international headquarters in both Boston, Massachusetts and Basel, Switzerland, PharmaLogics services both large Bio-pharma companies like Shire and Novartis as well as small, venture backed firms like NEON and Phosphorex. PharmaLogics places hundreds of talented scientists every year and has been recently recognized as an Inc. 5000 Fastest Growing Private Company in America for four consecutive years, an Inc. Magazine Top Workplace, a Staffing Industry Analysts Fastest Growing Staffing Firm, a Boston Globe Top Workplace, and a Boston Business Journal Best Place to Work and Fastest growing company.

Megan is a staunch advocate for gender equality.  Motivated by the utter lack of females in leadership roles in both the public and private sector, Megan launched the social media campaign #doit4yourdaughters.

Julia Rashba-Step

Julia Rashba-Step is a senior pharmaceutical professional with an extensive background in biotechnology and pharmaceutical industries. Julia has an experience working at both small companies (Epic Therapeutics, Phosphorex) and global pharmaceutical companies including Baxter, Wyeth and Pfizer, where she held positions of growing responsibility, such as leading Novel delivery technologies group at Pfizer. Recently, Julia has joined Phosphorex as a Vice President of Research & Development and Alliance Management. In her new role, Julia is excited to help advance cutting edge innovative concepts into the critical programs working closely with Pharma and Biotech partners.

Julia’s technical background is in Pharmaceutical product development with the focus on drug product, advanced formulations and delivery aspects. Julia is passionate about translating patient-centric innovative concepts into commercially viable products. Julia is an active member of MBC (Massachusetts Biotechnology Council) Mentors group.

Julia is committed to both personal and professional development of junior colleagues. She served as a mentor at HBA and was a founding member of Women’s Leadership Network of Greater Boston at Pfizer where she actively helped women to advance their careers. Julia also received a life coach certificate from Strategic Interventions and uses her skills in professional development to help colleagues to build rewarding careers.

Pat Andrews

Pat S. Andrews has been the Chief Executive Officer of Boston Biomedical since April 2017. Ms. Andrews joined the Company in 2013 to establish and lead all aspects of commercial operations and medical affairs. Ms. Andrews’ extensive experience and proven track record of operational success will be instrumental in driving the Company forward into the next stage of growth and innovation through expanding our robust clinical pipeline, initiating additional clinical studies for our first-in-class compounds across multiple tumor types, and setting the foundation for future commercialization of late-stage compounds.

Prior to joining Boston Biomedical, Ms. Andrews served as Executive Vice President and Chief Commercial Officer at Incyte, a U.S.-based biopharmaceutical company, where she led the transition from a clinical-stage research and development organization to a successful commercial enterprise, with the launch of its first-for-the-company, first-in-class, first-in-disease orphan oncology product. She established the commercial organization and led all functions within sales and marketing. She was also responsible for business development and completed multiple significant product licensing deals for Incyte, including one of the largest licensing deals in biotech in 2009.

Before working at Incyte, Ms. Andrews spent 17 years at Pfizer, culminating in her role as Vice President and General Manager of the U.S. Oncology Business Unit, a $900 million portfolio of products in colorectal cancer, breast cancer, and renal cell carcinoma. Ms. Andrews received her MBA from the University of Michigan and a BA from Brown University.